11
Views
0
CrossRef citations to date
0
Altmetric
Cardiovascular Medicine

Influence of tricuspid regurgitation on the prognosis of patients with cardiogenic shock

, ORCID Icon, , , , , , , , , & show all
Received 17 Nov 2023, Accepted 07 May 2024, Published online: 05 Jun 2024

References

  • Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the framingham heart study). Am J Cardiol. 1999;83(6):897–902.
  • Sadeghpour A, Hassanzadeh M, Kyavar M, et al. Impact of severe tricuspid regurgitation on long term survival. Res Cardiovasc Med. 2013;2(3):121–126.
  • Arsalan M, Walther T, Smith RL, et al. Tricuspid regurgitation diagnosis and treatment. Eur Heart J. 2017;38(9):634–638.
  • Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129(23):2440–2492. doi: 10.1161/CIR.0000000000000029.
  • Mutlak D, Lessick J, Khalil S, et al. Tricuspid regurgitation in acute heart failure: is there any incremental risk? Eur Heart J Cardiovasc Imaging. 2018;19(9):993–1001. doi: 10.1093/ehjci/jex343.
  • Topilsky Y, Khanna A, Le Tourneau T, et al. Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension. Circ Cardiovasc Imaging. 2012;5(3):314–323.
  • Kolte D, Kennedy KF, Passeri JJ, et al. Temporal trends in prevalence of tricuspid valve disease in hospitalized patients in the United States. Am J Cardiol. 2020;125(12):1879–1883. doi: 10.1016/j.amjcard.2020.03.033.
  • Schwartz LA, Rozenbaum Z, Ghantous E, et al. Impact of right ventricular dysfunction and tricuspid regurgitation on outcomes in patients undergoing transcatheter aortic valve replacement. J Am Soc Echocardiogr. 2017;30(1):36–46.
  • Sagie A, Schwammenthal E, Newell JB, et al. Significant tricuspid regurgitation is a marker for adverse outcome in patients undergoing percutaneous balloon mitral valvuloplasty. J Am Coll Cardiol. 1994;24(3):696–702.
  • Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43(3):405–409.
  • Bar N, Schwartz LA, Biner S, et al. Clinical outcome of isolated tricuspid regurgitation in patients with preserved left ventricular ejection fraction and pulmonary hypertension. J Am Soc Echocardiogr. 2018;31(1):34–41.
  • Benfari G, Antoine C, Miller WL, et al. Excess mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction. Circulation. 2019;140(3):196–206.
  • Sadeh B, Itach T, Merdler I, et al. Prognostic implication of tricuspid regurgitation in ST-segment elevation myocardial infarction patients. Isr Med Assoc J. 2021;23(12):783–787.
  • Jullien T, Valtier B, Hongnat JM, et al. Incidence of tricuspid regurgitation and vena caval backward flow in mechanically ventilated patients. A color doppler and contrast echocardiographic study. Chest. 1995;107(2):488–493. doi: 10.1378/chest.107.2.488.
  • Kompotiatis P, Wiley BM, Jentzer JC, et al. Echocardiographic parameters of patients in the intensive care unit undergoing continuous renal replacement therapy. PLOS One. 2019;14(1):e0209994. doi: 10.1371/journal.pone.0209994.
  • Artucio H, Hurtado J, Zimet L, et al. PEEP-induced tricuspid regurgitation. Intensive Care Med. 1997;23(8):836–840. doi: 10.1007/s001340050419.
  • Thiele H, Akin I, Sandri M, et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017;377(25):2419–2432.
  • Thiele H, Ohman EM, de Waha-Thiele S, et al. Management of cardiogenic shock complicating myocardial infarction: an update 2019. Eur Heart J. 2019;40(32):2671–2683. doi: 10.1093/eurheartj/ehz363.
  • Akodad M, Schurtz G, Adda J, et al. Management of valvulopathies with acute severe heart failure and cardiogenic shock. Arch Cardiovasc Dis. 2019;112(12):773–780.
  • Zeymer U, Bueno H, Granger CB, et al. Acute cardiovascular care association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: a document of the acute cardiovascular care association of the european society of cardiology. Eur Heart J Acute Cardiovasc Care. 2020;9(2):183–197. doi: 10.1177/2048872619894254.
  • Abraham J, Blumer V, Burkhoff D, et al. Heart failure-related cardiogenic shock: pathophysiology, evaluation and management considerations: review of heart failure-related cardiogenic shock. J Card Fail. 2021;27(10):1126–1140.
  • Barnett CF, Brusca SB, Hanff TC, et al. Management of cardiogenic shock unrelated to acute myocardial infarction. Can J Cardiol. 2023;39(4):406–419. Apr
  • Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the european society of cardiology (ESC). Developed with the special contribution of the heart failure association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975. doi: 10.1002/ejhf.592.
  • McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(48):4901–3726.
  • van Diepen S, Katz JN, Albert NM, et al. Contemporary management of cardiogenic shock: a scientific statement From the American heart association. Circulation. 2017;136(16):e232–e268. doi: 10.1161/CIR.0000000000000525.
  • Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. J Am Coll Cardiol. 2013;62(16):e147–239.
  • Baran DA, Grines CL, Bailey S, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American college of cardiology (ACC), the American heart association (AHA), the society of critical care medicine (SCCM), and the society of thoracic surgeons (STS) in april 2019. Cathet Cardio Intervent. 2019;94(1):29–37. doi: 10.1002/ccd.28329.
  • Naidu SS, Baran DA, Jentzer JC, et al. SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies: this statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) association for acute cardiovascular care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in december 2021. J Am Coll Cardiol. 2022; 879(9):933–946. doi: 10.1016/j.jacc.2022.01.018.
  • Antunes MJ, Rodríguez-Palomares J, Prendergast B, et al. Management of tricuspid valve regurgitation: position statement of the european society of cardiology working groups of cardiovascular surgery and valvular heart disease. Eur J Cardiothorac Surg. 2017;52(6):1022–1030. doi: 10.1093/ejcts/ezx279.
  • Neuhold S, Huelsmann M, Pernicka E, et al. Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational study. Eur Heart J. 2013;34(11):844–852.
  • Zweck E, Thayer KL, Helgestad OKL, et al. Phenotyping cardiogenic shock. J Am Heart Assoc. 2021;10(14):e020085.
  • Sinha SS, Rosner CM, Tehrani BN, et al. Cardiogenic shock from heart failure versus acute myocardial infarction: clinical characteristics, hospital course, and 1-Year outcomes. Circ Heart Fail. 2022;15(6):e009279.
  • Drazner MH, Hamilton MA, Fonarow G, et al. Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. J Heart Lung Transplant. 1999;18(11):1126–1132.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.